Cargando…
Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic condition associated with mutations in the LMNA gene. This disease recapitulates some aspects of normal aging, such as hair loss, thin skin, joint stiffness, and atherosclerosis. The latter leads to heart attack or stroke that causes deat...
Autores principales: | Gabriel, Diana, Shafry, Dinah Dorith, Gordon, Leslie B., Djabali, Karima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630293/ https://www.ncbi.nlm.nih.gov/pubmed/29029393 http://dx.doi.org/10.18632/oncotarget.19363 |
Ejemplares similares
-
Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts
por: Gabriel, Diana, et al.
Publicado: (2015) -
Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition
por: Marji, Jackleen, et al.
Publicado: (2010) -
Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes
por: Kreienkamp, Ray, et al.
Publicado: (2016) -
Impact of MnTBAP and Baricitinib Treatment on Hutchinson–Gilford Progeria Fibroblasts
por: Vehns, Elena, et al.
Publicado: (2022) -
Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype
por: Gabriel, Diana, et al.
Publicado: (2016)